Institutional Ownership Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV). We have compiled data on the 25 institutions that hold shares in the stock, with a total of 2.57 Million shares, which have been reported (via 13F filing form) to have a value of $4.04 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Armistice Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
1,413,306
shares
|
$2.22 Million
0.03% of portfolio
|
Q2 2025
Reduced 20.69%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
612,200
shares
|
$961,154
0.0% of portfolio
|
Q2 2025
Reduced 8.49%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
219,149
shares
|
$344,063
0.0% of portfolio
|
Q2 2025
Reduced 5.0%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
168,392
shares
|
$264,375
0.0% of portfolio
|
Q2 2025
Reduced 7.11%
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
61,052
shares
|
$95,851
0.0% of portfolio
|
Q2 2025
Reduced 24.4%
|
|
|
Sigma Investment Counselors Inc
|
Jul 29, 2025 Q2 2025 |
28,000
shares
|
$43,960
0.0% of portfolio
|
Q4 2024
Reduced 6.67%
|
|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
15,000
shares
|
$23,550
0.09% of portfolio
|
Q2 2022
Reduced 40.0%
|
|
|
Neuberger Berman Group LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
10,988
shares
|
$17,251
0.0% of portfolio
|
Q2 2025
Reduced 21.51%
|
|
|
Sky View Investment Advisors, LLC
Shrewsbury, NJ |
Aug 15, 2025 Q2 2025 |
10,000
shares
|
$15,700
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
9,184
shares
|
$14,418
0.0% of portfolio
|
Q2 2024
Reduced 8.1%
|
|
|
Group One Trading, L.P.
Chicago, IL |
Aug 13, 2025 Q2 2025 |
7,000
shares
|
$10,990
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Signaturefd, LLC
Atlanta, GA |
Jul 16, 2025 Q2 2025 |
5,000
shares
|
$7,850
0.0% of portfolio
|
Q4 2024
Added 66.67%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
3,044
shares
|
$4,779
0.0% of portfolio
|
Q2 2025
Added 1283.64%
|
|
|
Steward Partners Investment Advisory, LLC
|
Aug 12, 2025 Q2 2025 |
2,500
shares
|
$3,925
0.0% of portfolio
|
Q4 2024
Reduced 16.67%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Aug 13, 2025 Q2 2025 |
2,142
shares
|
$3,362
0.0% of portfolio
|
Q2 2025
Reduced 68.21%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,913
shares
|
$3,003
0.0% of portfolio
|
Q1 2025
Reduced 25.39%
|
|
|
Srs Capital Advisors, Inc.
Denver, CO |
Aug 12, 2025 Q2 2025 |
1,015
shares
|
$1,593
0.0% of portfolio
|
Q4 2024
Added 65.04%
|
|
|
Bfsg, LLC
|
Jul 14, 2025 Q2 2025 |
1,000
shares
|
$1,570
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Activest Wealth Management
|
Jul 29, 2025 Q2 2025 |
1,000
shares
|
$1,570
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Spire Wealth Management
|
Aug 04, 2025 Q2 2025 |
500
shares
|
$785
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Red Tortoise LLC
Atlanta, GA |
Jul 22, 2025 Q2 2025 |
150
shares
|
$235
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
57
shares
|
$89
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Sargent Bickham Lagudis LLC
|
Jan 23, 2023 Q4 2022 |
15
shares
|
$23
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|